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ABSTRACT  
 
Ferroptosis is an iron-dependent form of 
programmed cell death characterized by the 
accumulation of lipid-targeting reactive oxygen 
species that kill cells by damaging their plasma 
membrane. The lipid-repair enzyme glutathione 
peroxidase 4 (GPX4) protects against this 
oxidative damage and enables cells to resist 
ferroptosis. Recent work has revealed that matrix-
detached carcinoma cells can be susceptible to 
ferroptosis and that they can evade this fate 
through the signaling properties of the α6β4 
integrin, which sustains GPX4 expression. 
Although these findings on ferroptosis are 
provocative, they differ from those in previous 
studies indicating that matrix-detached cells are 
prone to apoptosis, via a process referred to as 
anoikis. In an effort to reconcile these discrepant 
findings, here we observed that matrix-detached 
epithelial and carcinoma cells cluster 
spontaneously via a mechanism that involves the 
cell adhesion protein PVRL4 (also known as 
Nectin-4). We found that this clustering process 
allows these cells to survive by stimulating a 
PVRL4/α6β4/Src signaling axis that sustains 
GPX4 expression and buffers against lipid 
peroxidation. In the absence of α6β4, PVRL4-
mediated clustering induced an increase in lipid 
peroxidation that was sufficient for triggering 
ferroptosis. When the clustering was inhibited, 
single cells did not exhibit a significant increase in 
lipid peroxidation in the absence of α6β4, and they 
were more susceptible to apoptosis than to 
ferroptosis. These results indicate that ferroptosis 
induction depends on cell clustering in matrix-
detached cells that lack α6β4 and imply that the 
fate of matrix-detached cells can be determined by 
the state of their cell–cell interactions.  
________________________________________ 
         Ferroptosis is defined as an iron-dependent 
form of programmed cell death that is 
characterized by the accumulation of intracellular 
soluble and lipid reactive oxygen species (ROS) 
that damage the plasma membrane by peroxidation 
of polyunsaturated fatty acids (1). At a 
mechanistic level, ferroptosis is triggered by the 
loss of activity of the lipid repair enzyme 
glutathione peroxidase 4 (GPX4), which catalyzes 
the reduction of lipids and other peroxides and is a 
target of several ferroptosis inducers (2). The 
antiporter system XC-, which imports cystine into 
the cell in exchange for glutamate, also has a 
critical role in protecting against ferroptosis 
because cysteine, the monomeric form of cystine, 
is a building block for the antioxidant glutathione 
(GSH), which is a co-factor for GPX4 (3,4). 
Molecules that inhibit system xC- such as erastin 
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trigger ferroptosis and have proven to be useful for 
studying this process in detail (4,5).  
 Rapid progress is being made in 
unraveling the biochemical nature of ferroptosis 
and determining its role in specific biological and 
pathological processes. A central theme that is 
emerging from these studies is the essential role of 
GPX4 in enabling cells to resist ferroptosis, a role 
that is particularly important for more aggressive 
tumor cells (6). Less is known, however, about the 
cell biological context of the mechanisms used to 
either promote or evade ferroptosis. Recently, we 
discovered that ferroptosis is a component of cell 
death induced by the detachment of epithelial and 
carcinoma cells from matrix (7). We also observed 
that the a6b4 integrin has the ability to confer 
ferroptosis resistance under these conditions. In 
other terms, matrix-detached cells undergo 
ferroptosis but only in the absence of a6b4. The 
mechanism underlying this phenomenon involves 
the ability of a6b4 to sustain GPX4 expression 
and activity in matrix-detached cells and buffer the 
increase in lipid peroxidation that occurs in these 
cells, which can trigger ferroptosis (7). 
Our findings on ferroptosis are 
provocative, but they differ from prior studies 
concluding that matrix-detached cells are prone to 
apoptosis, a process referred to as anoikis, unless 
survival mechanisms are enabled (8) (9). In an 
effort to reconcile these discrepant findings, we 
observed that matrix-detached epithelial and 
carcinoma cells cluster spontaneously by a 
mechanism that involves PVRL4 (also known as 
Nectin-4). If this clustering is inhibited, single 
cells are more susceptible to apoptosis in the 
absence of a6b4. Based on these observations, we 
explored the possibility of a functional connection 
between cell clustering and ferroptosis. Indeed, the 
data we report reveal that ferroptosis is dependent 
on cell clustering in matrix-detached cells that lack 
a6b4. 
 
RESULTS 
Matrix-detached cells cluster spontaneously by 
a mechanism that is independent of a6b4:  Our 
interest in understanding the distinction between 
ferroptosis and apoptosis in matrix-detached 
carcinoma cells was piqued by the observation that 
immortalized mammary epithelial (MCF10-A) and 
breast carcinoma cells (SUM-159 and Hs578t) 
cluster spontaneously upon detachment (Figure 
1A and B). These clusters could be dissociated 
into single cells with either 0.5% methylcellulose 
or 2mM EDTA (Figure 1A and B). Interestingly, 
we did not observe significant differences in 
cluster number upon depletion of a6b4 using 
CRISPR/Cas9 to knock-down the b4 subunit using 
two guide RNAs that target different regions of the 
first exon of ITGB4 (referred to as b4-3 and b4-4) 
(Figure 1B, C), indicating that this integrin does 
not contribute to clustering.  
 
Clustering of matrix-detached cells influences 
the relative levels of ferroptosis and apoptosis 
in the absence of a6b4:  The observations 
described above prompted us to assess the role of 
cell clustering in ferroptosis that is triggered by the 
loss of a6b4. For this purpose, we assayed cell 
viability 24 hrs after matrix detachment as a 
function of a6b4 expression in clustered cells or 
single cells (MCF10-A, SUM-159 and Hs578t) 
that had been generated using either 
methylcellulose or EDTA. These cells, which 
express a6b4, remained viable 24hrs after matrix-
detachment regardless of their clustering status 
(Figure 2A-C). In response to loss of a6b4 by 
CRISPR/Cas9-mediated knock-down of the b4 
subunit, however, a dramatic decrease in viability 
was seen in all conditions (Figure 2A-C), 
confirming the importance of the a6b4 integrin in 
maintaining survival in response to stress. It is 
important to note that CRISPR-mediated depletion 
of the b4 subunit in these cells does affect 
expression of the a6 integrin subunit and they 
express the a6b1 integrin (7). Specificity is also 
evidenced by our previous finding that expression 
of b4 construct that cannot be targeted by these 
CRISPRs in b4-depleted cells rescued their 
viability in ECM-detached conditions (7).   
Moreover, the a3b1 integrin does not promote 
ferroptosis resistance in these cells (7).    
To determine whether the nature of cell 
death differed between clustered and single 
detached cells in the absence of a6b4, we 
compared the ability of ferrostatin-1, ZVAD-fmk 
or both inhibitors to rescue the viability of 
detached, a6b4-depleted cells in the presence or 
absence of either methylcellulose or EDTA. In the 
absence of methylcellulose or EDTA either 
inhibitor alone yielded a partial rescue of viability 
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and the use of both inhibitors resulted in a 
complete rescue (Figure 2A), indicating that 
ferroptosis and apoptosis contribute to the death of 
these cells. Interestingly, though, ferrostatin-1 was 
unable to rescue viability in the presence of 
methylcellulose or EDTA (single cells) but 
ZVAD-fmk did rescue viability almost completely 
(Figures 2B, C). These results indicate that cell 
clustering pre-disposes cells to ferroptosis in the 
absence of a6b4, and that disruption of these 
clusters results in apoptosis.  Moreover, the 
finding that a6b4-depleted cells are prone to both 
ferroptosis and apoptosis in the absence of EDTA 
and methylcellulose probably reflects the fact this 
population is comprised of a mixture of clustered 
and single cells (Figure 1A). 
 
Lipid peroxidation is significantly higher in 
clustered, detached cells compared to single 
cells in the absence of a6b4:  To understand why 
clustered but not single cells are prone to 
ferroptosis in the absence of a6b4, we quantified 
lipid peroxidation, which is the root cause of 
ferroptosis, using the malondialdehyde (MDA) 
assay. Indeed, depletion of a6b4 resulted in a 
marked increase in lipid peroxidation in clustered 
but not single cells (Figure 3A). This finding 
suggests that the clustering of detached cells has 
the potential to increase lipid peroxidation to 
levels that are sufficient to trigger ferroptosis and 
that a6b4 mitigates these effects on clustered 
cells. The observation that detached single cells do 
not exhibit this increase in lipid peroxidation is 
consistent with our finding that these cells are not 
susceptible to ferroptosis.   
 The above results suggest that a6b4 
function differs between detached clustered and 
single cells, and that this integrin facilitates a 
mechanism to evade ferroptosis in detached, 
clustered cells.  Based on our previous work (7), 
we focused on the ability of a6b4 to induce GPX4 
expression and activity in these distinct 
populations. We observed that GPX4 mRNA 
(Figure 3B) and protein (Figure 3C) expression 
increased significantly upon matrix-detachment of 
clustered cells (2 hours), but that this increase was 
less evident in single cells.  The increase in GPX4 
expression is dependent on a6b4, consistent with 
our previous results (7). Moreover, the viability of 
the clustered, a6b4-depleted cells was rescued by 
either the lipophilic antioxidant a-tocopherol 
(Figure 3D) or exogenous expression of GPX4 
(Figure 3E). In contrast, neither a-tocopherol nor 
GPX4 re-expression in the a6b4-depleted, single 
cells rescued viability. These data infer that a6b4 
signaling differs between clustered and single, 
matrix-detached cells. Given that the induction of 
GPX4 expression upon matrix detachment is 
dependent on a6b4/Src signaling (7), we assessed 
Src activation in detached clustered and single 
cells as a function of a6b4 expression. Matrix-
detachment caused an increase in activated Src as 
assayed by Y418 immunoblotting in clustered 
cells that was dependent on a6b4 expression and 
not detected in either EDTA or methylcellulose-
treated cells (Figure 3F).  
 
PVRL4 mediates clustering of matrix-detached 
cells and ferroptosis resistance: An important 
issue that arose from our data is the mechanism by 
which matrix-detached cells cluster and the 
contribution of this mechanism to ferroptosis 
resistance. The possibility that this clustering is 
mediated by E-cadherin is negated by the fact that 
two of the cell lines we studied (SUM-159 and 
Hs578t) have a mesenchymal phenotype and 
express little, if any, E-cadherin. We confirmed 
this assumption by treating matrix-detached cells 
with a function-blocking E-cadherin Ab 
(DECMA-1) and observing no effect on clustering 
(Figure 4A). Interestingly, however, DECMA-1 
had no effect on the percent of MCF10-A cells in 
clusters, although it did cause a significant 
decrease in the number of large (10+ cells) clusters 
(Figure 4B). In contrast, treatment of adherent 
MCF10-A cells with DECMA-1 disrupted cell-cell 
adhesion (Figure 4C). For this reason, we focused 
on the cell surface receptor PVRL4 (also referred 
to as nectin-4) because it has been shown to 
mediate the clustering of matrix-detached 
carcinoma cells by interacting in trans with 
PVRL1 (10). Importantly, PVRL4 also maintains 
the survival of these cells by interacting with a6b4 
in cis and enabling Src activation (10). These 
seminal studies, however, did not consider a 
potential role for PVRL4 in ferroptosis resistance. 
For this reason, we initially examined the ability 
of a function-blocking PVRL4 Ab to disrupt the 
clustering of matrix-detached cells and found that 
this Ab was as effective as either EDTA or 
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methylcellulose in disrupting clusters into single 
cells (Figure 4A).  Depletion of b4 did not 
significantly affect PVRL4 expression in b4-
depleted cells (Figure 4D). 
The above finding prompted us to assess 
the contribution of PVRL4 to the cell death that 
occurs upon matrix-detachment. Matrix-detached 
cells that express a6b4 exhibited no significant 
loss of viability in response to treatment with the 
PVRL4 function-blocking antibody compared with 
IgG control (Figure 5A), supporting our 
conclusion that this integrin promotes the survival 
of clustered and single, matrix-detached cells. As 
we reported previously (7), matrix-detached cells 
that lack a6b4 exhibit a dramatic loss of viability 
that is rescued by ferrostatin-1. In marked contrast, 
a6b4-depleted cells treated with the PVRL4 
function-blocking antibody exhibited a significant 
loss of viability that was rescued by ZVAD-fmk 
and not ferrostatin-1 (Figure 5B). This result 
indicates that disruption of PVRL4-mediated 
clustering of a6b4-depleted cells renders them 
sensitive to apoptosis as opposed to ferroptosis, 
and that PVRL4 is necessary to execute ferroptosis 
in this population of cells.  
Given that a6b4-mediated Src signaling 
maintains the survival of matrix-detached cells (7), 
we examined the impact of the PVRL4 function-
blocking antibody on Src activation in matrix-
detached cells.  Indeed, disruption of cell 
clustering by this antibody resulted in a significant 
decrease in Src activation comparted to control 
cells as assessed by phospho-Src (Y418) 
immunoblotting (Figure 5C).  A causal role for 
Src activation in ferroptosis resistance is indicated 
by the observation Src inhibition using PP2 
decreased the viability of clustered, matrix-
detached cells significantly, and that this loss of 
viability was rescued by ferrostatin-1 but not 
ZVAD-fmk. (Figure 5D).  Together, these results 
indicate that PVRL4-mediated clustering is 
necessary for a6b4-mediated Src activation. 
 
DISCUSSION 
The results of this study reveal an intimate 
relationship between the clustering of matrix-
detached carcinoma cells and ferroptosis. We 
conclude from our data that matrix-detached 
carcinoma cells cluster spontaneously and that this 
clustering triggers an increase in lipid peroxidation 
that is sufficient to induce ferroptosis. Ferroptosis 
can be evaded under these conditions if these cells 
express the a6b4 integrin, which functions to 
buffer lipid peroxidation by sustaining GPX4 
expression. In marked contrast, dissociation of 
clustered, detached cells into single cells results in 
apoptosis in the absence of a6b4. An important 
and novel inference from these data is that the fate 
of matrix-detached cells can be determined by the 
state of their cell-cell interactions. 
Our findings build upon the seminal study 
by Elledge and colleagues that identified PVRL4 
in a gain of function screen for genes that promote 
the survival of matrix-detached carcinoma cells 
(10). Not only did they implicate PVRL4 in the 
clustering of matrix-detached carcinoma cells and 
anoikis resistance, they also demonstrated that 
PVRL4 enables a6b4-mediated Src activation and 
the importance of this pathway in the survival of 
these detached cells. Our work substantiates these 
findings and extends them to ferroptosis 
resistance. Indeed, we demonstrate that the 
PVRL4/a6b4/Src axis allows matrix-detached 
cells to resist ferroptosis by sustaining GPX4 
expression and minimizing lipid peroxidation, 
establishing a novel role for PVRL4 in ferroptosis 
resistance mechanisms.  Interestingly, however, 
we also show that PVRL4 can promote ferroptosis 
in the absence of a6b4 by mediating cell 
clustering and contributing, either directly or 
indirectly, to increased lipid peroxidation. In other 
terms, this observation implies that the process of 
cell clustering mediated by PVRL4 stimulates an 
increase in lipid peroxidation by a mechanism to 
be determined, and that this scenario does not 
occur in single cells, which do not engage PVRL4-
mediated adhesion.  
Previous studies have noted the role of 
cell ‘aggregation’ in promoting apoptosis 
resistance in matrix-detached squamous carcinoma 
and ErbB2-expressing MCF10-A mammary 
epithelial cells (11) (12).  These studies focused on 
cells that expressed E-cadherin and they 
implicated E-cadherin as the mediator of cell 
aggregation and apoptosis resistance.  For this 
reason, our finding that PVRL4 mediates the 
clustering of matrix-detached MCF10-A cells is 
intriguing and raises the need to investigate the 
relationship between E-cadherin- and PVRL4-
mediated cell-cell adhesion. Our primary interest, 
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however, is on survival mechanisms used by 
aggressive carcinoma cells, which often exhibit a 
mesenchymal phenotype and express little, if any, 
E-cadherin (13). In fact, the carcinoma cell lines 
used in our study are mesenchymal when grown as 
adherent cells but retain the ability to engage in 
cell-cell adhesion upon matrix-detachment, a 
scenario that mimics the transition from aggressive 
primary carcinomas to circulating tumor cells, 
which tend to cluster (14). 
Although studies on the nature of cell 
death triggered by matrix-detachment have 
focused largely on apoptosis, it is becoming 
apparent that other modes of cell death can occur 
that involve elevated ROS levels (15,16). Our 
findings establish ferroptosis as one such ROS-
mediated form of cell death. They also provide 
insight into the cell biological parameters that 
influence ferroptosis by revealing how the 
clustering of matrix-detached carcinoma cells can 
promote ferroptosis as opposed to apoptosis. On a 
broader level, the role of ferroptosis in eliminating 
matrix-detached carcinoma cells is timely and 
significant based on the recent realization that 
aggressive carcinoma cells with a mesenchymal 
phenotype are highly sensitive to ferroptosis 
unless they enable mechanisms that sustain GPX4 
expression (6). Based on our data, 
PVRL4/a6b4/Src signaling in the context of cell 
clustering could be one such mechanism. 
 
EXPERIMENTAL PROCEDURES  
Cell lines and reagents: MCF10-A cells were 
obtained from the Barbara Ann Karmanos Cancer 
Institute and SUM-159 cells were provided by Dr. 
Stephen Ethier (Medical College of South 
Carolina). Hs578T cells were provided by Dr. 
Dohoon Kim (UMass Medical School). MCF10-A 
cells were maintained in DMEM/F-12 (Gibco) 
with 5% horse serum, 1% pen/strep (Gibco), 
20ng/mL EGF (Peprotech), 0.5mg/mL 
hydrocortisone (Gibco), 100ng/mL cholera toxin 
(Sigma), and 10ug/mL insulin (Sigma). SUM-159 
cells were maintained in F-12 (Gibco) medium 
with 5% fetal bovine serum (Hyclone), 1% 
pen/strep, 0.5mg/mL hydrocortisone, and 
10ug/mL insulin. Hs578t cells were maintained in 
DMEM high glucose (Gibco) medium with 10% 
fetal bovine serum, 1% pen/strep, and 10ug/mL 
insulin. All cells were checked quarterly for 
mycoplasma and authenticated using the 
University of Arizona Genetic Core. The 
following antibodies were used: GPX4 (Abcam, 
ab125066), actin (Sigma-Aldrich), integrin β4 
(505 [Rabinovitz et al., 1999]), phospho-Src Y418 
(R&D Systems MAB2685), total Src (Santa Cruz 
Biotechnology sc-8056), DECMA-1 (Abcam 
(ab11512), PVRL4 (R&D Systems 17402 and Cell 
Signaling Technology 17402). Other reagents used 
were: ZVAD-fmk (SelleckChem), ferrostatin-1 
(Sigma-Aldrich), a-tocopherol (Sigma-Aldrich), 
PP2 (SelleckChem).   
 
Matrix-detachment assays: Twenty-four well 
plates were coated with 800uL of polyHEMA 
(30mg/mL, Sigma-Aldrich) and dried overnight at 
room temperature. Cells were trypsinized and 
complete medium was used to quench the trypsin. 
Cells were counted and the remaining suspension 
was diluted to 2.5 x 104 cells per 100uL and plated 
(100uL per well) in cell-line specific serum-free 
medium with the reagents indicated in the figure 
legends for the times noted. Four wells were 
plated per condition as technical replicates. Cells 
were counted with a hemocytometer using trypan 
blue exclusion. Total cell number was calculated 
by multiplying average cells per square by dilution 
factor and chamber volume.   
 
Biochemical experiments: For all experiments, 
three wells were plated per condition for each 
independent experiment as technical replicates, 
and at least three independent experiments were 
performed. For immunoblotting, cells collected in 
to pre-chilled tubes and spun down before washing 
twice in ice-cold PBS. Protein was extracted using 
RIPA buffer containing protease and phosphatase 
inhibitors (Boston Bioproducts, Worcester, MA, 
USA) by lysing cells 15 minutes on ice followed 
by centrifugation at maximum speed for 15 
minutes at 4ºC. Supernatant was collected and 
protein concentration quantified using Bradford 
reagent (Bio-Rad). Samples (25ug protein) were 
separated by SDS-PAGE and immunoblotted 
using the Abs specified in the figure legends. For 
qPCR, RNA was isolated from cells using the 
NucleoSpin Gel and PCR Clean-Up kit 
(Macherey-Nagel). Briefly, cells were collected, 
lysed immediately following centrifugation, and 
RNA isolated following manufacturer’s kit 
specifications.  RNA concentrations were 
determined by Nanodrop and cDNA (1ug per 
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sample) was produced using the All-In-One cDNA 
Synthesis SuperMix (BioScript). qPCR was 
performed using a Cyber Green master mix 
(BioTool). Sequences for primers used are as 
follows: 18s Forward 5’-
AACCCGTTGAACCCCATT-3’, Reverse 5’-
CCATCCAATCG GTAGTAGCG-3’, derived 
from NT_167214.1, GPX4 Forward 5’-
GAGGCAAGACCGAAGTAAACTAC-3’, 
Reverse 5’-CCGAACTGGTTACACGGGAA-3’, 
derived from NC_000019.10.  
To assay lipid peroxidation, the 
Malondialdehyde (MDA) Lipid Peroxidation 
microplate assay (Sigma-Aldrich) was used 
according to the manufacturer’s specifications. 
Briefly, cells (1x106) were cultured in cell-line 
specific, serum-free medium on polyHEMA-
coated plates for 4 hours. Three wells were plated 
per condition for each independent experiment as 
technical replicates. Cells were collected, lysed 
and reacted with thiobarbituric acid (TBA) for one 
hour at 95ºC.  An aliquot of lysate (5 uL) was 
saved for protein concentration determination 
using the Bradford assay prior to reaction with 
TBA. Fluorescence was read at 532(ex)/590(em). 
Lipid peroxidation levels were normalized to 
protein concentration.  
 
Molecular biology experiments: For CRISPR-
mediated deletion of the b4 integrin subunit, guide 
RNAs (sgRNA) targeting exon 1 of the b4 
sequence were selected using two websites, 
CRISPR Design (http://crispr.mit.edu) and 
CRISPRdirect (https://crispr.dbcls.jp). Four guide 
RNAs were tested and the two most efficient 
knockouts were. Guide RNA sequences used 
were: B4-3 5’ 
CACCGTTGTCCAGATCATCGGACA 3’, 
5’AAACTGTCCGATGATCTGG ACAAC 3’. 
B4-4 5’ CACCGAAATCCAATAGTGTAGTCGC 
3’, AAACGCGACTACACTAT TGGATTTC 3’. 
Cells were sub-cloned by FACS and screened for 
loss of protein expression by immunoblot. New 
CRISPR-depleted cells were generated every three 
months to control for potential secondary effects 
caused by long-term gene depletion. To express 
GPX4, a plasmid construct for GPX4 was 
purchased from Origene (RC208065). Cells were 
transfected with 10µg of DNA using 
Lipofectamine 2000 (ThermoFisher) and 
incubated for 48 hours prior to use.  
 
Statistical Analysis: The bars in graphs represent 
mean ± standard deviation. All experiments were 
repeated at least three times. P-values were 
calculated using ANOVA and a p-value less than 
0.05 was considered significant.   
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FIGURE LEGENDS 
Figure 1. Breast epithelial and carcinoma cells preferentially cluster upon matrix detachment (A) 
MCF10-A, SUM-159 and Hs578t cells (vector and β4-depleted) were detached and allowed to cluster 
spontaneously or treated with either 2mM EDTA or 0.5% methylcellulose to generate single cell 
suspensions. Photomicrographs were taken 2 hrs post-detachment. Bar = 10 microns. (B) Quantification 
of MCF10-A, SUM-159 and Hs578t clusters was performed by counting the total number of single and 
clustered cells, total number of clusters (defined as ≥ 3 cells). Six independent photos of each cell line and 
each condition were quantified. (C) The β4 integrin subunit was depleted in Hs578t cells by 
CRISPR/CAS9 using two independent guide RNAs (β4-3 and β4-4). Depletion of β4 expression was 
verified by immunoblotting.  
Figure 2. Clustering of matrix-detached cells influences the relative levels of ferroptosis and 
apoptosis in the absence of a6b4. (A) Control and b4-depleted cells were detached for 24 hrs in the 
presence of either DMSO, ferrostatin-1 (2µM), ZVAD-fmk (25µM) or ferrostatin-1 and ZVAD-fmk and 
the number of viable cells was quantified.  (B) Control and b4-depleted cells were detached for 24 hrs 
with 2mM EDTA in the presence of either DMSO, ferrostatin-1 (2µM), ZVAD-fmk (25µM) or 
ferrostatin-1 and ZVAD-fmk and the number of viable cells was quantified. (C) Control and b4-depleted 
cells were detached for 24 hrs with 0.5% methylcellulose in the presence of either DMSO, ferrostatin-1 
(2µM), ZVAD-fmk (25µM) or ferrostatin-1 and ZVAD-fmk and the number of viable cells was 
quantified.   
 
Figure 3. Clustering of matrix-detached cells influences lipid peroxidation, GPX4 expression and 
Src activity. (A) Lipid peroxidation was quantified using the MDA assay in control and b4-depleted 
MCF10-A and SUM-159 cells under either adherent, detached clustered (no additive) or detached single 
(0.5% methylcellulose) conditions for 4 hrs. Similar results were obtained using 2mM EDTA. (B) GPX4 
mRNA expression was quantified by qPCR in control and b4-depleted cells MCF10-A and SUM-159 
cells under either adherent, detached clustered (no additive) or detached single (0.5% methylcellulose) 
conditions for 2 hrs. (C) GPX4 protein expression was assessed by immunoblotting in control MCF10-A, 
SUM-159 and Hs578t cells in detached clustered (no additive) or detached single (0.5% methylcellulose) 
conditions for 4 hrs.  Immunoblots were quantified by densitometry and the ratio of the intensity of the 
GPX4/actin bands relative to adherent cells is shown under the blots.  (D) SUM-159 b4-depleted cells 
were detached for 24 hrs with either no additive (Clustered) or 2mM EDTA (Single) in the presence of 
either DMSO or 500mM a-tocopherol, and the number of viable cells was quantified. (E) Control and 
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b4-depleted cells SUM-159 cells that had been transfected with either a vector control or a GPX4 
expression vector were detached for 24 hours with no additive (Control) or 0.5% methylcellulose, and the 
number of viable cells was quantified. (F) SUM-159 and Hs578t control cells were assessed for 
phosphorylated (Y418) Src by immunoblotting in adherent conditions as well as following two hours of 
matrix-detachment with no additive (NA), 2mM EDTA (EDTA), or 0.5% methylcellulose (MC). 
 
Figure 4. PVRL4 mediates clustering upon matrix-detachment. (A) MCF10-A, SUM-159, and 
Hs578t vector control cells were detached and allowed to aggregate in the presence of 4ug/mL of either 
IgG, DECMA-1 or a PVRL4-blocking Ab.  Photomicrographs were taken 2 hrs post-detachment. Bar = 
10 microns.  (B) Quantification of MCF10-A, SUM-159 and Hs578t clusters was performed by counting 
the total number of single and clustered cells, total number of clusters (defined as ≥ 3 cells) and the 
number of large clusters (defined as ≥10 cells). (C) MCF10-A cells were detached and allowed to re-
adhere in the presence of either IgG or DECMA-1. Photomicrographs were taken at 24h. Bar = 10 
microns. (D) SUM-159 control and b4-depleted cells under adherent, detached clustered or detached 
single cell conditions were assessed for expression of PVRL4 mRNA by qPCR.  
 
Figure 5. PVRL4-mediated cell clustering is necessary for a6b4-dependent Src activation. (A) 
SUM-159 and Hs578t control cells were detached for 24 hrs in the presence of either IgG or a PVRL4 Ab 
and the number of viable cells was quantified. (B) SUM-159 and Hs578t b4-depleted cells were detached 
for 24 hrs in the presence of either IgG and DMSO, PVRL4 Ab, PVRL4 Ab and ferrostatin-1 (2µM) or 
PVRL4 and ZVAD-fmk (25µM), and the number of viable cells was quantified. (C) MCF10-A, SUM-
159 and Hs578t control cells were detached for 2 hours in the presence of either IgG or a PVRL4-
blocking Ab, and phosphorylation of Src (Y418) was assessed by immunoblotting. (D) Cells (MCF10-A 
and SUM-159) were assessed for viability after 24 h of detachment (clustered conditions) in the presence 
of either DMSO, PP2 (10µM) or PP2 in combination with either ferrostatin-1 (2 µM) or ZVAD-fmk 
(25µM). 
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